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Background: Several studies have shown that Blastomyces dermatitidis, the etiologic agent of blastomycosis, is a
genetically diverse pathogen. Blastomycosis is a significant health issue in humans and other mammals. Veterinary
and human isolates matched with epidemiological case data from the same geographic area and time period were
used to determine: (i) if differences in genetic diversity and structure exist between clinical veterinary and human
isolates of B. dermatitidis and (ii) if comparable epidemiologic features differ among veterinary and human
blastomycosis cases.
Results: Genetic typing of 301 clinical B. dermatitidis isolates produced 196 haplotypes (59 unique to veterinary
isolates, 134 unique to human isolates, and 3 shared between canine and human isolates). Private allelic richness
was higher in veterinary (median 2.27) compared to human isolates (median 1.14) (p = 0.005).
Concordant with previous studies, two distinct genetic groups were identified among all isolates. Genetic group
assignment was different between human and veterinary isolates (p < 0.001), with more veterinary isolates assigned
to Group 2.
The mean age of dogs diagnosed with blastomycosis was 6 years. Thirty cases were in male dogs (52%) and 24
were females (41%). The breed of dog was able to be retrieved in 38 of 58 cases with 19 (50%) being sporting
breeds. Three of four felines infected with blastomycosis were domestic shorthair males between ages 6–12, and
presented with disseminated disease. The other was a lynx with pulmonary disease. The equine isolate was from an
11-year-old male Halflinger with disseminated disease. Disseminated disease was reported more often in veterinary
(62%) than human cases (19%) (p < 0.001).
Conclusions: Isolates from all hosts clustered largely into previously identified genetic groups, with 3 haplotypes
being shared between human and canine isolates confirming that B. dermatitidis isolates capable of infecting both
species occur in nature. Allelic diversity measures trended higher in veterinary samples, with a higher number of
total alleles and private alleles. Veterinary isolates of B. dermatitidis contributed a substantial amount of diversity to
the overall population genetic structure demonstrating the importance of including veterinary isolates in genetic
studies of evolution and virulence in this organism.
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Blastomycosis is a significant health issue in humans and
other mammals. This fungal infection often presents as
a non-specific febrile illness that mimics viral and bac-
terial pneumonia, causing cough, fever, hospitalization
and sometimes death. Moreover, dissemination of the in-
fection to bone, skin, central nervous system and other* Correspondence: meece.jennifer@mcrf.mfldclin.edu
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reproduction in any medium, provided the ororgans is often observed. In dogs, it is thought to pre-
dominantly affect young, male, large sporting breeds,
chiefly because of their propensity for outdoor activity
[1-4]. Only Minnesota considers canine blastomycosis a
reportable disease, therefore the number of cases occur-
ring nationally is grossly underestimated. In Minnesota,
canine cases occurred at 2.5 times that of humans from
1999–2009 [5]. Studies in Arkansas and Wisconsin re-
port incidence of canine blastomycosis to be 10–13
times that of humans [6,7]. In highly endemic areas,
incidence rates reach 1-2% annually, and in one 10 yearral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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was observed [3]. Although reported less frequently, blasto-
mycosis infections in felines show similar symptomology
and severity [8,9].
Several studies, have explored the genetic diversity of
Blastomyces dermatitidis, the etiologic agent of blastomyco-
sis [10-12]. More recently, genetic characterization using
microsatellite markers has revealed that B. dermatitidis is a
genetically diverse pathogen [13] with the 2 princi-
pally divergent genetic groups being associated with
different clinical phenotypes in humans [14]. Previous
studies have focused on the genetics of human clinical
isolates as isolates from veterinary sources are less avail-
able for research. It is unknown whether canine, or
other veterinary, clinical isolates of B. dermatitidis ex-
hibit genetic diversity similar to human isolates or
whether genetic groups could be associated with specific
clinical phenotypes, as has been shown in humans.
Veterinary and human isolates matched with epi-
demiological case data from the same geographic area
and time period were used to determine: (i) if differences
in genetic diversity and structure exist between clinical
veterinary and human isolates of B. dermatitidis and (ii)
if comparable epidemiologic features differ among veter-
inary and human blastomycosis cases. The results of this
study will provide a more complete understanding of the
population genetic diversity of B. dermatitidis from a
wider range of host species and assess the existence of
host-specific and shared genotypes.
Methods
Isolates
The majority of isolates used in this study are part of the
Marshfield Clinic Research Foundation’s B. dermatitidis
bio-bank, which have been collected through our rela-
tionship with Marshfield Labs since 1999. Over this
period Marshfield Clinic Research Foundation has
obtained an extensive library of human and veterinary
clinical isolates including 57 cultures of B. dermatitidis
from canines, 4 from felines, and 1 equine isolate. In
addition, we were gifted an isolate obtained from the
stool of a dog diagnosed with acute blastomycosis [15].
The human and veterinary isolates used in this study
were collected over the same time period and geographic
area. It is unknown whether any isolates in this study
were acquired from epidemiologically linked owners and
pets, both diagnosed with blastomycosis.
Genetic analysis
DNA was extracted from all veterinary B. dermatitidis
isolates (n = 63) and genotyped with 27 microsatellite
markers as previously described [13]. Up to 3 attempts
were made for isolates that did not amplify initially for a
given locus. Veterinary isolate genotyping data werecombined with previously genotyped human isolates
(n = 238). Rarefacted allelic and private allelic richness
[16,17] were calculated with HPRARE [18] employing
a rarefaction method to account for unequal sample
sizes in the two isolate sets. Non-parametric Wilcoxon
signed rank tests were used to compare genetic diver-
sity estimates between human and veterinary isolates
of B. dermatitidis.
Genetic analyses focused on delineating genetic struc-
ture, predicting clusters of related isolates, and compar-
ing the diversity of strains across the different host
species. Briefly, genetically identical isolates were identi-
fied using Genetic Analysis in Excel v6.41 [19] and sub-
sumed to representative haplotypes. The program
STRUCTURE [20] was used to predict the minimum
number of genetic clusters (K) within the composite
data, with analysis settings as previously described [14].
The method of Evanno et al. [21] as employed by Struc-
ture Harvester [22] was used to estimate the most likely
K given the data in conjunction with the mean and vari-
ance of the ln probability of K across multiple replicates.
Principle coordinate analysis (PCoA) of the standardized
covariance of the haplotypic genetic distance as performed
in Genetic Analysis in Excel v6.41 was used to ana-
lyse and graphically plot clusters of haplotypes. Iso-
lates were assigned to genetic group based on haplotypic
results from both STRUCTURE and PCoA analysis. A
Chi-square test was used to assess difference in ge-
netic group assignment between human and veterinary
isolates.Medical record review
The test accession number was retrieved from each clin-
ically confirmed isolate of B. dermatitidis and used to
obtain the following information on each veterinary pa-
tient: city and state of veterinary clinic submitting the
sample for testing; age, breed, and gender of the veterin-
ary patient; and sample source. Location of infection was
inferred from the sample source submitted for testing
and cases were categorized as pulmonary only or dis-
seminated infections (which were presumed to have
originated as a respiratory infection). Samples submitted
for culture that led to a classification of pulmonary dis-
ease included: tracheal or transtracheal wash, bronchial
lavage, lung biopsy, and respiratory secretions. Samples
classified as obtained from disseminated disease in-
cluded biopsies or discharge collected from masses or le-
sions on any part of the body not considered part of the
respiratory tract. Clinical information associated with
each human isolate was obtained previously for another
study [14]. A Chi-square test was used to assess diffe-
rences in location of infection between human and vete-
rinary cases.
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Genetic analysis
Typing of B. dermatitidis veterinary isolates (n = 63)
across 27 loci yielded a 97.5% success rate. Forty-three
alleles were unable to be determined as a result of either
failed PCR or null alleles. Most of these undetermined
alleles (n = 35) were from 3 isolates, obtained in 2001
and 2002. After genetic typing of veterinary isolates was
completed and combined with previously typed human
isolates, a total of 301 isolates represented 196 distinct
haplotypes (59 unique to veterinary isolates, 134 unique
to human isolates, and 3 shared between canine and hu-
man isolates). A summary of haplotypic allele diversity
of B. dermatitidis isolated from veterinary and human
hosts is shown in Table 1. The total number of alleles
and private alleles identified in veterinary isolates was
higher than those in human isolates (Table 1). TheTable 1 Haplotypic allele diversity of B. dermatitidis isolated f
Veterinary haplotypes (n = 59) H
Locus # of alleles # of private alleles # of all
1 4 1 3
2 8 0 8
3 13 3 12
4 10 3 7
5 8 4 5
6 14 3 13
7 9 3 7
8 9 2 10
9 7 2 6
10 9 1 9
11 12 3 11
12 8 0 10
13 8 0 8
14 9 0 9
15 7 0 8
16 12 3 9
17 5 1 6
18 11 1 14
19 9 3 11
20 12 5 10
21 12 3 10
22 11 3 10
23 7 2 6
24 7 3 5
25 6 0 8
26 13 5 9
27 10 1 10
Totals 250 55 234
Summary of haplotypic allele diversity of B. dermatitidis isolated from veterinary and
unique haplotypes; 59 unique to veterinary isolates, 134 unique to human isolates,median (adjusted mean # of alleles/locus) rarefacted al-
lelic richness of veterinary isolates and human isolates
was 9.26 and 8.13, respectively. Testing the null hypoth-
esis that overall allelic richness is the same in veterinary
and human isolates showed no significant difference
(Wilcoxon signed ranks 2-tailed, p = 0.1319). However,
private allelic richness differed significantly between vet-
erinary isolates (median = 2.27) and human isolates (me-
dian = 1.14) (Wilcoxon 2-tailed, p = 0.0050) with 20 of
27 loci having higher private allelic richness for vete-
rinary versus human isolates. In addition, a subsequent
1-tailed Wilcoxon signed ranks test showed veterinary
private allelic richness was greater than human private
allelic richness (Wilcoxon 1-tailed, p = 0.0025).
STRUCTURE analysis of the unique haplotypes re-
solved two genetic clusters (K = 2) in the data based on
the method of Evanno et al. [21] and the linearity androm veterinary and human hosts
uman haplotypes (n = 134) Shared haplotypes (n = 3)





























human hosts. The 301 clinical B. dermatitidis isolates were subsumed to 196
and 3 shared between veterinary and human isolates.
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haplotype (q-value) based on K = 2 revealed 191 haplo-
types with a majority q-value >80% (Figure 1). Five hap-
lotypes (1, 61, 111, 134, and 190, representing only one
isolate each) had a majority q-value <80%. Principal co-
ordinate analysis (Figure 2) confirmed clustering of the
haplotypes, primarily, into 2 distinct groups. Fifty per-
cent of variance was accounted for by the first principle
coordinate (Coordinate 1) and separated Group 1 and 2
isolates. The secondary axis (Coordinate 2) explained
an additional 16% of variance. The 5 haplotypes (num-
bered in Figure 2) with <80% ancestral membership in
STRUCTURE analysis, were observed to be genetic in-
termediates by PCoA analysis and could not be assigned
to either genetic group. After removing genetic interme-
diates (1 canine isolate and 4 human isolates), Group 1
contained 48 haplotypes (representing 17 veterinary iso-
lates and 135 human isolates). Group 2 contained 143
haplotypes (representing 45 veterinary isolates and 99
human isolates). Testing the null hypothesis that group
assignment is the same for veterinary and human iso-
lates showed that significantly more canine isolates were
assigned to Group 2 (chi-square = 17.98, 1 df, p < 0.001).
Although not statistically supported by STRUCTURE
analysis as a separate genetic group, visual examinationFigure 1 STRUCTURE analysis of B. dermatitidis haplotypes. Mean q-va
isolates) with K = 2. Group 1 haplotypes are shown in black and Group 2 h
isolates. Haplotype 55 represents the single equine isolate. Haplotypes 56–
represent exclusively human isolates. Haplotypes 88, 92, and 195 contained
190, representing only one isolate each) had a majority q-value <80% andof Figure 2 reveals a small cluster of exclusively human
isolates within Group 2.
Medical record review
Samples were submitted for either fungal or aerobic cul-
ture testing by 42 veterinary clinics in 34 cities through-
out Wisconsin, Illinois, Michigan and Minnesota. The
highest numbers of samples submitted for culture over
the 13 year period were received from veterinary clinics
in Buffalo Grove, IL (n = 6), Plover, WI (n = 5), and Ap-
pleton, WI (n = 5). The age range of dogs diagnosed
with blastomycosis was 1–17 years (mean 6), with 8
cases having unspecified ages. Thirty cases were male
dogs (52%), 24 were female (41%), and 4 had unspecified
gender (7%). The highest numbers of isolates were
obtained in 2006, 2007, and 2009 with 9, 13, and 8 iso-
lates cultured, respectively, in each of those years. The
breed of dog was able to be retrieved in 38 of 58 cases
with 19 (50%) being purebred sporting breeds (Table 2).
Three of the 4 felines were domestic shorthair (Felis
catus) neutered males between the ages of 6–12 and
presented with disseminated disease. The other was a
lynx (Lynx canadensis), which presented with pulmonary
disease, and its age and gender were not specified. The
equine isolate was obtained from an 11-year-old Halflingerlues from STRUCTURE for all 196 unique haplotypes (representing 301
aplotypes in gray. Haplotypes 1–54 represent exclusively canine
59 represent feline isolates. Haplotypes 61–87, 89–91, 93–194, and 196
both human and canine isolates. Five haplotypes (1, 61, 111, 134, and
could not be assigned to either genetic group.
Figure 2 Principle coordinate analysis of B. dermatitidis haplotypes. Principle coordinate analysis of the haplotypic pairwise covariance
distance matrix for all 196 unique haplotypes (representing 301 isolates). Fifty percent of variance was accounted for by the first principle
coordinate (coordinate 1) and separated Group 1 and 2 isolates. The five numbered haplotypes represent single isolates with a mean majority
q-values <80% in STRUCTURE results and could not be assigned to either genetic group.
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disseminated disease.
Twenty-one (33%) veterinary infections were identified
as pulmonary, whereas 39 (62%) were classified as dis-
seminated infections. Three infections were unable to be
classified based on available information. The location of
infection in human cases, abstracted from medical charts
as previous described, showed 190 (80%) were pulmo-
nary, 46 (19%) were disseminated, and 2 (< 1%) infectionsTable 2 Breeds of 58 canines diagnosed with
blastomycosis










1breeds belonging to AKC sporting group.
2Mixed breeds included 1 mixed Doberman, 1 mixed Labrador retriever,
1 mixed Golden retriever, and 1 mixed Rottweiler/German shepard.
3Other includes one each of the following breeds: Alaskan malamute, Beagle,
Australian cattle dog, Chow chow, German shorthaired1, Siberian husky, Jack
russell terrier, Shetland sheepdog, Treeing walker coonhound, Weimaraner1,
and Yorkshire terrier.had undetermined location [14]. Testing the null
hypothesis that location of infection is the same in
veterinary and human cases showed a significant
difference in the number of pulmonary and dissemi-
nated infections between human and veterinary cases
(chi-square = 48.399, 1 df, p < 0.001).
Discussion
Studies exploring the genetic diversity of B. dermatitidis
have primarily focused on human clinical isolates as
clinical isolates obtained from veterinary sources are less
available to researchers. It is unknown whether canine,
or other veterinary, clinical isolates of B. dermatitidis ex-
hibit genetic diversity similar to human isolates or
whether genetic groups could be associated with specific
clinical phenotypes, as has been shown in humans [14].
Understanding strain level phenotypic variation across
host species could help us better anticipate clinical
symptoms and outcomes and potentially inform treat-
ment options.
Genotyping of veterinary isolates with these previously
published microsatellite markers continued to provide a
reliable and informative tool for assessing population
level diversity. Compared to human isolates, the veterin-
ary isolates had a slightly lower genotyping success rate.
Most of the missing genotype data came from 3 of the
oldest isolates in our collection (obtained in 2001 and
2002) and are likely the result of DNA degradation. The
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markers and likely represent genuine alleles (null alleles)
especially since repeated attempts were made to amp-
lify missing alleles. Furthermore these markers were
initially designed from genomic sequence of a human
B. dermatitidis isolate [13]. Given the larger number
of total and private alleles detected in canine isolates
of B. dermatitidis, it is probable that alleles exist in ca-
nine isolates that the primers sets used in this study can-
not detect. Missing alleles are not reported in counts of
the number of alleles or the number of private alleles
shown in Table 1. However isolates with missing alleles
were left in the haplotypic analysis.
In the current study, PCoA and STRUCTURE analyses
resolved veterinary and human isolates intermixed
within previously identified genetic groups with no dis-
tinct resolution of veterinary isolates discrete from hu-
man isolates. Allelic diversity measures trended higher
in veterinary samples, with a higher number of total and
private alleles, despite the more than two-fold higher
number of haplotypes in the human isolates. Three hap-
lotypes were shared between human and canine isolates
confirming that B. dermatitidis isolates capable of
infecting both humans and canines occur in nature. Des-
pite this, a large number of alleles (94 of 289, 33%) and
most haplotypes (193 of 196, 98%) were not shared be-
tween host species. In fact, all four feline isolates and
the single equine isolate comprise unique haplotypes in-
dividually. One notable observational finding is the pres-
ence of a small genetic cluster within Group 2 that is
exclusively comprised of human isolates. Veterinary iso-
lates of B. dermatitidis contributed a substantial amount
of diversity to the overall population genetic structure
demonstrating the importance of including veterinary
isolates in genetic studies of evolution and virulence in
this organism.
B. dermatitidis isolates exhibit considerable population
genetic diversity by microsatellite typing. This is espe-
cially true of Group 2 isolates regardless of the host spe-
cies from which it is isolated. This may indicate that
other factors, such as genetic recombination rates and
ecological or environmental partitioning, may impact
the population genetic structure of B. dermatitidis as
has been observed in the closely related fungal patho-
gens Coccidioides and Penicillium marneffei [23,24].
Very little work has been done exploring genetic recom-
bination in B. dermatitidis. Although B. dermatitidis can
reproduce sexually, the mating-type locus was only re-
cently identified [25], and it is unknown how frequently
sexual reproduction occurs in nature. The rate of recom-
bination between and among the 2 major genetic groups
of B. dermatitidis could significantly impact the popula-
tion genetic structure of this pathogen. Further explor-
ation of ecological partitioning could also provideinteresting insight into the genetic structure and evolu-
tion of B. dermatitidis. Mapping of exposures and the
identification of point-source outbreaks have provided
clues about the growth requirements and preferred en-
vironmental conditions of B. dermatitidis [26,27]. Al-
though no apparent geospatial relationships have been
identified in the distribution of B. dermatitidis, this work
has been previously hindered by the limited number of
environmental isolates and cultured clinical isolates with
associated exposure data. It is possible that spatial
partitioning exists on a more subtle level and is
impacting the genetic diversity of B. dermatitidis. It is
also recognized that B. dermatitidis exists in the envir-
onment in geographically-restricted microfoci that are
apparently short-lived [28]. This may complicate at-
tempts at fully understanding spatial relationships as
time and seasonality may also play a role [29].
Another explanation of the varying levels of genetic di-
versity between host species observed in this study is
that they are the result of host sampling. Canines and fe-
lines are exposed to a wider range of environments and
in more direct environmental contact than humans. For
example, the amount of direct contact and exposure of
dogs (both surface area covered and time exposed dir-
ectly to that surface) to the moist soil environments
thought to be the primary habitat of B. dermatitidis is
immeasurably higher than that of even the most-avid
outdoorsman. Thus, dogs should be a better representa-
tive or sampling vector of the species diversity than the
limited exposures available in human isolates. This is es-
pecially relevant to researchers as environmental isolates
are rare. As seen in previous epidemiologic studies of ca-
nine blastomycosis, we observed a high rate of infection
in male, sporting breed dogs. Unexpectedly, we found
that the mean age of infected dogs in our study was
higher than in previous reports [2-4,7].
Veterinary isolates were obtained more often from
cases of disseminated disease versus pulmonary disease.
This may be due to delay of diagnosis in dogs as owners
may fail to notice the initial symptoms of blastomycosis,
which can present as a non-specific febrile illness. Alter-
natively, it may be the result of intrinsic disease differ-
ences in varying host species, unrelated to strain type.
One difference in disease manifestation that has been
observed between humans and dogs is the higher rate of
eye dissemination in dogs, which to date, has remained
unexplained. However, the higher rate of dissemination
in dogs may be a bias of our study associated with the
ease of obtaining a biopsy in a disseminated case versus
a sample such as a bronchial wash, which would be ne-
cessary in the case of pulmonary only disease presenta-
tion. Due to this, we felt confident classifying the disease
location in veterinary cases based on the assumption
that a veterinarian would not submit a pulmonary
Anderson et al. BMC Veterinary Research 2013, 9:84 Page 7 of 8
http://www.biomedcentral.com/1746-6148/9/84sample if another sample could be obtained with a less
invasive procedure. Therefore, any isolates for which we
had a non-respiratory sample were considered dissemi-
nated infections. Samples that were unable to be classi-
fied as either disseminated or pulmonary infections
included one unidentified sample and two obtained from
the nares. As blastomycosis is acquired by inhalation of
spores, it is possible that an infection in the nares could
be due to direct inoculation instead of dissemination
from the lung and therefore we chose not to classify
these cases as disseminated infections.
Another interesting finding of this study was that sig-
nificantly more veterinary isolates (45 of 62, 73%), than
human isolates (99 of 234, 42%) were genetic Group 2
organisms. In a recently conducted study, we found that
genetic Group 2 infections are more often associated
with disseminated disease in humans [14]. We were un-
able to directly assess association between genetic group
and location of infection in veterinary cases in this study,
because of the small number of Group 1 isolates. Des-
pite this challenge, we observed a greater number of
cases of disseminated disease in our veterinary cohort,
with the predominant genetic group being Group 2 in
these isolates. This is consistent with the associations
established in the aforementioned study. If these results
can be definitively verified across host species, it may in-
dicate a molecular basis for differences in clinical pheno-
type observed between the two genetic groups.
Despite the patterns and correlations observed in this
study, several limitations should be addressed in future
research. The statistical power of this study is limited by
the relatively small number of veterinary isolates and
retrospective nature. Although culture is the primary
diagnostic method for human blastomycosis, this may
not be true of canine blastomycosis. This is supported
by the fact that only 57 cultures of B. dermatitidis were
isolated from canine sources by Marshfield Labs from
1999–2011. Certainly this collection of cultured isolates
does not represent the clinical or genetic spectrum of
canine blastomycosis, as veterinarians may be more
likely to order culture under specific clinical circum-
stances such as more severe disease, obvious dissemin-
ation, value of pet, and a myriad of other factors. By
partnering with veterinarians to obtain a less biased col-
lection of isolates, future research can further explore
the genetic diversity of veterinary blastomycosis. Al-
though all clinical veterinary B. dermatitidis cultures
used in this study were isolated and diagnosed in the
same laboratory, over the same period of time and were
obtained from the same geographic range as the human
isolates to which they were compared, it must be recog-
nized that this collection of isolates represents a limited
geographic range of this global species. Despite the
small number of veterinary isolates evaluated, thismanuscript represents the largest genotyping study of
canine B. dermatitidis isolates.
Conclusions
Genetic typing and comparison of veterinary and human
isolates revealed that they were intermixed within previ-
ously identified genetic groups with no distinct reso-
lution of veterinary isolates discrete from human
isolates. Allelic diversity measures trended higher in vet-
erinary samples, with a higher number of total and pri-
vate alleles. Three haplotypes were identified as shared
between human and canine isolates confirming that
B. dermatitidis isolates capable of infecting both
humans and canines occur in nature. Veterinary iso-
lates of B. dermatitidis contributed a substantial amount
of diversity to the overall population genetic structure
demonstrating the importance of including veterinary iso-
lates in genetic studies of evolution and virulence in this
organism.
Another finding of this study was that significantly
more veterinary isolates (73%), than human isolates
(42%) were genetic Group 2 organisms and cultured iso-
lates of B. dermatitidis from veterinary patients were
more likely to be obtained from cases of disseminated
disease than humans. This finding suggests that previous
associations of genetic group of B. dermatitidis with spe-
cific clinical phenotypes in humans [14] may also hold
true in veterinary infections.
The continued study of B. dermatitidis across its range
of hosts and geography is key to a better understanding
of the life cycle, evolution, and virulence, of this clinic-
ally important pathogen.
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